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different maneuvers are described in Table 1. As he no longer
exhibited the previously observed BP fall with pressor
stimulation, we did not feel compelled to draw arterial blood
gas samples. Of note, his respiratory rate was unchanged,
though we did not measure his tidal volume.
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To the Editor: The article by Hedayati et al.1 is relevant in
that it addresses the important but underrecognized problem
of depression in the dialysis population. The goal of the study
was to investigate whether an association exists between
physician-diagnosed depression and poor outcomes. The
paper underscored the high prevalence of depression in this
population and illustrated the significant morbidity and
mortality associated with the combined diagnosis of depres-
sion and dialysis.
The authors did a good job of addressing most of the
clinical characteristics that could affect the outcome of
hospitalizations and mortality. However, phosphorus and
calcium, two clinical characteristics associated with mortality
outcomes in the dialysis population were not addressed.
The inclusion of phosphorus and calcium is highly
important in the analysis, as these biochemical markers are
associated with the outcome.2 Phosphorus in particular
should have been evaluated, as it is more difficult for the
observer to control relative to parathyroid hormone and
calcium and is dependent on the behavior of the subject, in
regard to both dietary discretion and adherence to binder
therapy. Depression by definition influences behavior; it is
essential to know if the difference in mortality between the
two patient groups can be attributed at least in part to a
difference in phosphorus and or calcium.
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The letter by Brown1 appropriately highlights the significance
of calcium and phosphorus as predictors of poor outcomes in
end-stage renal disease patients on chronic dialysis, and
inquires why these variables were not included in the
multivariable model for outcomes in our study. We recognize
that previous observational studies have shown a correlation
between phosphorus and calcium-phosphorus product and
death in this patient population.2 Earlier studies have also
shown a direct relationship between depressive symptoms
and non-adherence to diet and interdialytic weight gain in
chronic hemodialysis patients, although to our knowledge, no
published data exist to show an association between higher
phosphorus, in particular, and presence of depression.3,4 It is
also known that decreased behavioral adherence is in turn
associated with decreased survival.4
In our study, mean calcium, phosphorus, and para-
thyroid hormone levels were not significantly different
among depressed vs non-depressed patients. The baseline
Table 1 | Blood pressure and heart rate responses to pressor
maneuvers
Blood pressurea
(mm Hg)
Heart rate
(bpm)
Mental stressb
Baseline 152/82 100
End 144/78 100
Handgrip (30 s)
Baseline 126/62 75
End 158/80 88
Cold pressor (30 s)
Baseline 132/60 78
End 160/78 88
All tests performed in the supine position. They are reported above in the order they
were performed. 5 min of rest separated each maneuver from the next.
aValues reflect the average of three readings at each point of measurement.
bMental stress: serial 7s counted down from 300.
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characteristics of the cohort based on the presence or
absence of depression has been previously published.5
Given the lack of correlation between these variables and
depression in bivariate models, these variables were not
included in the multivariable model. In addition, the
number of events (52) limited the inclusion of too many
covariates at the risk of over-fitting the model. We agree
with Brown that perhaps one mediator between depression
and poor outcomes could be that those with depression are
more non-adherent to dietary and fluid restrictions, which
in turn leads to worse outcomes.6 Future larger studies are
warranted to address these important questions.
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To the Editor: We read with great interest the article by
Fukui M and colleagues1 evaluating the relationship between
serum bilirubin and albuminuria in patients with type II
diabetes. In this paper, the authors performed a number of
correlations and a multiple regression analysis and concluded
that the serum bilirubin level is associated with microalbu-
minuria and subclinical atherosclerosis in type II diabetic
patients.
However, these results should be interpreted with caution,
as in most of the correlations, the Pearson’s r value was below
0.2, implying a very poor correlation.2 For example, the
coefficient of determination (r2) for bilirubin pulse wave
velocity and bilirubin ankle brachial index, which are early
preclinical markers of atherosclerosis, are 0.1142¼ 0.013 and
0.1182¼ 0.0139, respectively. That is, the proportion of
variance that the variables have in common is 1.3 and
1.39%, respectively; the remaining 98.7 and 98.61% would
probably be explained by other factors, perhaps by HbA1c
levels or other parameters common and sufficiently proven to
be atherogenic in diabetic patients. The fact that these weak
correlations were statistically significant can be explained by
the large sample size of the study but does not mean that
these values are fair enough to imply any important
correlation between the examined variables. Similarly, the
adjusted R2 as well as the tolerance values in the multiple
regression model should be presented, as there seems to be a
degree of co-linearity (between age and duration of diabetes,
BMI, or systolic blood pressure) that might destabilize the
model and lead to indefinite results (for example, triglycer-
ides but not cholesterol were independent determinants of
log (urinary albumin excretion)).
In our opinion, it is quite venturesome and unwarranted
to discuss the potential preventive and therapeutic applica-
tions of bilirubin or its diagnostic utility as a new risk factor
for diabetic nephropathy and atherosclerosis based on the
current data.
1. Fukui M, Tanaka M, Shiraishi E et al. Relationship between serum bilirubin
and albuminuria in patients with type 2 diabetes. Kidney Int 2008; 74:
1197–1201.
2. Wayne DW. Biostatistics, 6th edn. John Wiley & Sons: New York, 1995.
Theodore I. Kassimatis1 and Dimitrios-Anestis Moutzouris1
1Department of Nephrology, Evangelismos General Hospital, Athens, Greece
Correspondence: Dimitrios-Anestis Moutzouris, Neo Psychico, 2 Miaouli Str,
Athens, 15451, Greece. E-mail: moutzouris@hotmail.com
Response to ‘Bilirubin as a
predictor of albuminuria and
atherosclerosis in type 2 diabetic
patients: misleading data’
Kidney International (2009) 75, 862–863; doi:10.1038/ki.2008.680
We would like to thank Drs Kassimatis and Moutzouris1
for their interest in our article,2 and the editor for the
opportunity to clarify the several points raised.
Certainly, the Pearson’s r-value between serum bilirubin
concentration and pulse wave velocity and between serum
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